CompanyScope

CVS Health Corporation revenue by year

Ticker CVS · SEC CIK 64803 · Latest fiscal year ended Dec 31, 2025

Over the 10 fiscal years shown, revenue went from $177.55B (year ended Dec 31, 2016) to $402.07B (year ended Dec 31, 2025), a compound annual growth rate of 9.5%. The fastest growth was +32.0% in the year ended Dec 31, 2019; the weakest year was +4.1% (year ended Dec 31, 2017).

$0$200B$400B$600BDec 2016: $177.55BDec 2017: $184.79BDec 2018: $194.58BDec 2019: $256.78BDec 2020: $268.71BDec 2021: $292.11BDec 2022: $322.47BDec 2023: $357.78BDec 2024: $372.81BDec 2025: $402.07BDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
CVS Health Corporation revenue by fiscal year, USD. Hover a bar for the exact figure.

Annual revenue

Fiscal year endedRevenue (USD)ChangeXBRL conceptReported in
Dec 31, 2025$402.07B+7.8%Revenues10-K filed Feb 10, 2026
Dec 31, 2024$372.81B+4.2%Revenues10-K filed Feb 10, 2026
Dec 31, 2023$357.78B+10.9%Revenues10-K filed Feb 10, 2026
Dec 31, 2022$322.47B+10.4%Revenues10-K filed Feb 12, 2025
Dec 31, 2021$292.11B+8.7%Revenues10-K filed Feb 7, 2024
Dec 31, 2020$268.71B+4.6%Revenues10-K filed Feb 8, 2023
Dec 31, 2019$256.78B+32.0%Revenues10-K filed Feb 9, 2022
Dec 31, 2018$194.58B+5.3%Revenues10-K filed Feb 16, 2021
Dec 31, 2017$184.79B+4.1%Revenues10-K filed Feb 18, 2020
Dec 31, 2016$177.55B+15.8%Revenues10-K filed Feb 28, 2019

Quarterly revenue

Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.

QuarterRevenue (USD)vs same quarter a year earlierSource
3 months ended Jun 30, 2026$106.10B+7.3%10-Q filed Aug 5, 2026
3 months ended Mar 31, 2026$100.43B+6.2%10-Q filed May 6, 2026
3 months ended Sep 30, 2025$102.87B+7.8%10-Q filed Oct 29, 2025
3 months ended Jun 30, 2025$98.92B+8.4%10-Q filed Aug 5, 2026
3 months ended Mar 31, 2025$94.59B+7.0%10-Q filed May 6, 2026
3 months ended Sep 30, 2024$95.43B+6.3%10-Q filed Oct 29, 2025
3 months ended Jun 30, 2024$91.23B+2.6%10-Q filed Jul 31, 2025
3 months ended Mar 31, 2024$88.44B+3.7%10-Q filed May 1, 2025

Source: SEC EDGAR XBRL company facts for CIK 64803 (raw data). Most recent filing in this dataset: 10-Q filed Aug 5, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.